Midi Health Alternatives: 9 Options Compared for 2026

Q: Is MyMenopauseRx still $99?

Its current main site publishes $150 per self-pay virtual visit. Older pages or comparisons showing $99 are stale. Insurance cost sharing depends on the exact plan.

The HRT Index Editorial TeamIndependent women's health research

Last reviewed:August 14, 2026

Editorial research — not medically reviewed by a clinician. Why this label

Last updated: August 14, 2026 · Last verified: August 14, 2026 · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

Match the replacement to the problem you need to solve

Use the source article's state, insurance, medication route, and safety-fit questions before you spend anything or cancel an existing prescription service.

Find My HRT Path

The best Midi Health alternatives depend on why you are leaving: Evernow or Gennev for commercial insurance, MyMenopauseRx for a $150 self-pay visit and pharmacy choice, Elektra for Medicare or Medicaid where available, Wisp for a $99 one-time consult, and Alloy, Hers, or Winona for medication-delivery plans. Check state and medication eligibility before paying.

Best for: women leaving Midi because of insurance-network fit, Medicaid or Medicare eligibility, cash-price predictability, medication delivery, state availability, or a care-model mismatch.

Not for you if: you want a diagnosis from an article, a guarantee that a clinician will prescribe a particular drug, or a way around an in-person evaluation when one is medically necessary. Start with our HRT benefits and risks guide if you are still deciding whether hormone therapy is the question at all.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Before the table: here is who pays us

We think you should know this before you read a single recommendation.

Sesame Care and Winona are affiliate partners. Midi Health is not currently an affiliate partner. We may earn a commission if you use a labeled affiliate link on this page.

Gennev, MyMenopauseRx, Elektra Health, Evernow, Alloy, Wisp, Hers, and Inner Balance pay us nothing on this page. Neither does the cheapest non-platform route: your own clinician and your own pharmacy.

The two providers that solve the clearest insurance problems on this page — Gennev and Elektra — are in the unpaid column. So is MyMenopauseRx, the provider with a published $150 self-pay visit and the ability to choose the same specialist again.

Every commercial fact below is tied to a provider page checked on August 14, 2026. Where a company’s own pages disagree, we say so instead of picking the version that converts better.

The 20-second answer

If you are leaving Midi because…	Start with	Published price structure	Keep Midi instead if…	Affiliate relationship?
Your plan does not cover Midi, but you still want commercial insurance billing	Evernow or Gennev	Evernow: $150 self-pay per video visit; Gennev: $250 initial, $199 follow-up if self-pay	Midi is in network and your charge was your deductible or coinsurance	No
You want a lower self-pay visit with a prescription sent to your pharmacy	MyMenopauseRx	$150 per virtual visit	You need care in a state MyMenopauseRx does not serve	No
You have Medicare or Medicaid	Elektra Health	Your plan cost share where in network; $249 initial and $149 follow-up if self-pay	Elektra is not licensed or not in network where you live	No
You want one low one-time consult and a retail-pharmacy prescription	Wisp	$99 menopause consult; medication separate	You need a scheduled live-video relationship or a published lab pathway	No
You want medication shipped in a cash-pay plan	Alloy, Hers, or Winona	Alloy and Hers publish medication prices; Winona publishes product subscriptions	You want insurance billed for the clinical visit or medicine from your own pharmacy	Winona only
You want a lab panel inside a menopause subscription	Sesame	Current price is shown during booking; five listed tests are included when ordered, with state exceptions	Your recent primary-care labs already cover what the panel measures	Yes
You want testosterone	Midi, Elektra in New York, or MyMenopauseRx where its current clinician/state rules allow direct prescribing	Prescription, follow-up, lab, and medication costs vary	None has a direct pathway where you are located — then use an in-person clinician	Midi only
You want the lowest total cost and already have a willing prescriber	Your own clinician + your own pharmacy	Your visit cost plus your exact pharmacy quote	You cannot get appropriate prescribing or follow-up locally	No

This is a decision table, not a treatment plan. A licensed clinician decides whether any medication is appropriate. Insurance cost sharing, prescriptions, labs, and pharmacy prices are separate unless the table says they are included.

What we actually verified

Under The HRT Index Verification Standard, here is exactly what we did — and did not — do.

We read the current pricing, insurance, state-access, treatment, lab, and cancellation pages published by each provider.
We separated the clinical fee from medication, lab, subscription, and insurance costs.
We separated FDA-approved products from compounded medications at the product level, not by treating an entire company as one regulatory category.
We checked testosterone access against provider pages and the federal Schedule III status of testosterone.
We rebuilt the cost comparisons from current published prices and printed the arithmetic.
We checked the same accountability sources for affiliate and non-affiliate providers.
We did not enroll, complete checkout, call an insurer, receive care, or test cancellation. This is editorial verification of published facts, not a first-person review.

The right online HRT provider is not the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer cannot resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care is not the right starting point — before your first consult.

→ See which providers can actually treat you — check state, insurance, medication route, and safety-fit questions before you spend anything.

What are the best Midi Health alternatives in 2026?

Evernow and Gennev are the strongest broad commercial-insurance alternatives; MyMenopauseRx is the clearest lower-price self-pay visit; Elektra is the decisive Medicare or Medicaid route where licensed; Wisp is the lowest published one-time consult; and Alloy, Hers, and Winona are medication-delivery models. Sesame stands out for its included basic lab panel.

Nine providers made the main comparison:

Evernow — all 50 states plus DC, commercial-insurance-eligible video visits, $150 self-pay per visit, and an optional membership.
Gennev — physician-led video care in all 50 states, 30-minute doctor visits, commercial insurance by specific plan, and $250/$199 self-pay pricing.
MyMenopauseRx — $150 per virtual visit, seven named insurance groups, same-specialist selection, and prescriptions sent to your pharmacy. Its FAQ currently says it directly prescribes testosterone for patients located in Illinois and may coordinate with a local PCP elsewhere; clinician-specific pages list additional states, so confirm the exact pathway before booking.
Elektra Health — commercial and government-plan contracts in specific states, clinician-plus-coach model, FDA-approved medications only, and a published testosterone pathway for patients in New York.
Wisp — $99 one-time menopause consult, with prescriptions sent to a pharmacy you choose if approved.
Alloy — cash-pay medication delivery, a one-time consult fee, ongoing messaging, and published product-by-product prices.
Sesame — cash-pay menopause subscription with five basic laboratory tests included when the clinician orders them, subject to state exceptions.
Hers — medication-included plans starting at $79 a month for oral options or $134 a month for patch options with a 12-month plan. A July 29, 2026 FTC-and-state complaint alleges deceptive billing, difficult cancellation, and unlawful sharing of sensitive health information; the case is pending and the allegations have not been adjudicated. Hers is not monetized on this page.
Winona — shipped subscription products, a 35–59 age rule, a limited state footprint, both commercially manufactured and compounded medication lanes, and every-28-day renewal language for 30-day supplies.

We also examined Inner Balance/Oestra. It remains in a separate compounded section because Oestra is not a like-for-like substitute for the FDA-approved medication lane most Midi patients use.

One thing to get straight now: a visit price, a monthly membership, and a medication-included subscription are three different numbers. A $150 visit can be cheaper than a $79 monthly plan, or much more expensive, depending on how often you need care and whether the medicine is included. That is why every cost table below names the unit being compared.

Before you switch: is Midi actually the problem?

Switching fixes a network mismatch, a government-insurance exclusion, an unavailable medication pathway, an age or state restriction, or a care-model mismatch. It does not erase a deductible. If Midi is in network and your insurer assigned the allowed charge to your deductible, another insurance-billing clinic can produce the same result.

We know why you are here. And we are not going to spend thousands of words talking you into a move the facts do not support.

Put your reason in one of three buckets.

Bucket 1: the bill

Midi publishes a $250 initial self-pay visit and $150 continued-care visits. For insured patients, it states that deductibles, coinsurance, and copays may still apply. That means “Midi takes my insurer” is not the same sentence as “my visit costs only a copay.” See Midi’s current pricing and insurance page.

If the claim processed correctly and the allowed charge went to your deductible, that is a deductible, not a special Midi fee. Evernow, Gennev, MyMenopauseRx, and Elektra can all create the same kind of bill when they bill insurance.

The structural fix is not another insurance logo. It is one of these:

verify the exact plan and current deductible before the visit;
choose a known self-pay visit price;
choose a medication-included cash plan;
or use your own in-network clinician.

Wanting a known number is a completely legitimate reason to leave. Just make sure the number is actually all in.

Bucket 2: one bad visit

A rushed appointment, a clinician who did not feel prepared, or a communication mismatch can be a provider problem without being a company problem. Ask for reassignment before you rebuild your care from zero.

That step is free. It also protects your refill runway while you decide.

Bucket 3: an actual wall

This is where switching earns its keep:

Midi cannot treat Medicaid or Medi-Cal patients, even as self-pay patients.
Midi does not bill Medicare, although Medicare beneficiaries may pay cash and may not submit Midi claims.
Midi’s testosterone program is limited to listed jurisdictions.
You want an included medication shipment rather than a prescription sent to a retail pharmacy.
You want a lower cash entrance price.
You want a different care format: 30-minute physician video, clinician-plus-coach, one-time asynchronous consult, or an ongoing subscription.

Buckets 1 and 2 may not need a new company. Bucket 3 usually does. The rest of this page is for Bucket 3 — and for anyone in Bucket 1 who has decided that a known cash price is worth more than the possibility of insurance savings.

Why do women leave Midi Health?

The clearest documented reasons are insurance cost sharing, Medicaid and Medi-Cal ineligibility, no Medicare billing, state-limited testosterone access, a $250 cash entrance price, medication and labs being separate, and a preference for medication delivery or a fixed subscription. Service complaints add clinician-continuity and portal-friction concerns, but no provider here guarantees the same clinician every time.

Reason for leaving	What is verified	What actually changes the situation
The insured bill was larger than expected	Midi says deductibles, coinsurance, and copays can apply	Verify the exact plan and deductible, or choose a known cash price
Medicaid or Medi-Cal	Midi says it cannot treat these patients even as self-pay	Elektra where licensed and in network, or the patient’s own Medicaid network
Medicare	Midi does not bill Medicare; beneficiaries may self-pay but cannot submit claims	Elektra where covered, Evernow/Gennev only if a separate commercial plan applies, or an in-network local clinician
$250 cash entry price	Midi’s published initial self-pay fee is $250	MyMenopauseRx or Wisp at a lower published cash entrance price; Evernow at $150 per self-pay video visit
Testosterone state restriction	Midi publishes 24 states plus DC	Elektra publishes access in New York; MyMenopauseRx’s FAQ says direct prescribing in Illinois while clinician pages list broader prescriber-specific states — confirm before booking, or use an in-person licensed prescriber
Medication and labs cost extra	Midi’s visit fee does not make prescriptions or outside labs free	Medication-included plans, or Sesame’s included five-test panel when ordered
Wants medication shipped automatically	Midi usually sends prescriptions to the patient’s pharmacy; compounded testosterone is handled through a compounding pharmacy	Alloy, Hers, Winona, or an Evernow delivery option
Wants the same clinician	Midi does not publish a same-clinician guarantee	MyMenopauseRx explicitly lets patients select the same specialist; still confirm availability
Wants phone access rather than portal-only care	Midi currently publishes a support phone number, email, and secure portal — so “no phone number” is no longer accurate	Choose the communication model you will actually use; ask about response times before paying

That last row matters. Some older comparisons described Midi as having no phone line. Midi now publishes telephone support, so that criticism is gone. A page that keeps a negative after the fact changes is not independent. It is just stale.

Which Midi Health alternatives actually take insurance?

Five providers in the main comparison bill or support commercial insurance for clinical visits: Midi, Evernow, Gennev, MyMenopauseRx, and Elektra Health. Coverage is plan- and state-specific. Elektra is the only provider in this comparison that publicly lists Medicare and Medicaid contracts; Alloy, Wisp, Sesame, Hers, and Winona are cash-pay care models.

All insurance facts below were checked August 14, 2026.

Provider	Insurance position	Published self-pay clinical price	Geography	What to verify before booking
Midi	In network with most PPO plans; names major carriers including Aetna, Cigna, Anthem/BCBS, and UnitedHealthcare	$250 initial; $150 continued care	All 50 states	Exact plan, specialist cost sharing, remaining deductible, medication formulary
Evernow	Insurance-eligible video visits; names UnitedHealthcare, Aetna, Anthem, and Blue Cross Blue Shield; no Medicare or Medicaid	$150 per video visit	All 50 states + DC	Exact plan and whether optional membership fees are separate
Gennev	Its live plan lookup includes Aetna, Anthem, Cigna, S&S/Meritain, and some out-of-network benefit arrangements; participation varies by plan	$250 initial doctor visit; $199 follow-up	All 50 states	Search the exact plan rather than relying on the carrier logo
MyMenopauseRx	Names Aetna, Blue Cross Blue Shield, Cigna, Humana, UnitedHealthcare, TRICARE, and Sana	$150 per virtual visit	39 states + DC listed on its site	State eligibility and exact plan participation
Elektra	State-specific commercial contracts plus listed Medicare and Medicaid plans	$249 initial; $149 follow-up	Clinical care in 16 states	State, exact plan, referral rule, and specialist cost sharing

“Takes insurance” is not “your plan is in network”

This is the sentence that would prevent most surprise-bill searches.

A company can contract with your carrier while your exact employer plan remains out of network. It can be in network and still leave you owing the allowed amount because your deductible is not met. It can cover the visit but not the prescribed brand, lab, or compounding-pharmacy charge.

Ask your insurer these questions and write down the representative’s name, date, and reference number:

Is the specific medical group or clinician billing my visit in network under my exact plan?
What is my remaining deductible today?
Is a menopause telehealth visit treated as primary care, specialist care, or another category?
What copay or coinsurance applies after the deductible?
Are the likely prescriptions on my formulary, and do they require prior authorization?
Which laboratory network must I use?

Ask about the deductible before you ask about the copay. It is often the whole answer.

Does this sound like your situation? Check Gennev’s live plan lookup and current self-pay prices. We earn nothing if you book with Gennev.

What if you have Medicare or Medicaid?

Midi cannot bill Medicare and cannot treat Medicaid or Medi-Cal patients even as self-pay. Elektra publicly lists Medicare and Medicaid contracts in specific states and says it became the first virtual menopause provider to accept both in 2024. If Elektra is unavailable, the correct route is your own plan’s in-network clinician — not a cash telehealth workaround that excludes your coverage.

Midi’s current policy is unusually clear:

Medicaid and Medi-Cal patients cannot be treated, even if they offer to self-pay.
Medicare beneficiaries can use Midi as self-pay patients, but cannot submit claims related to Midi visits, medications, or associated services.

Elektra’s current position is the opposite in the states and plans where it participates. Its public FAQ lists clinical care in New York, Connecticut, Massachusetts, Florida, Pennsylvania, New Jersey, Illinois, Arizona, Georgia, Iowa, Missouri, Nebraska, Ohio, Oklahoma, Tennessee, and Texas. Its plan lists include Medicare in several states and Medicaid in New York, Pennsylvania, New Jersey, and Illinois arrangements, with exact coverage varying by plan. See Elektra’s current FAQ.

Elektra also states that it prescribes only FDA-approved hormonal and non-hormonal medications, sends prescriptions to the patient’s preferred pharmacy, and adds a coach to the clinical-care model.

The catch, stated plainly: Elektra’s plan depth is stronger than its geographic breadth. Midi is in all 50 states; Elektra clinical care is in 16. “Elektra takes Medicaid” is useless if it does not treat patients where you are physically located or does not contract with your exact state plan.

If Elektra does not cover your location or plan, the unexciting true answer is your own Medicare or Medicaid network. Use the member directory and ask for gynecology, primary care, women’s health, or a menopause-trained clinician. A cash affiliate offer does not become better merely because it is easier to link.

If you have Medicare or Medicaid, start here: check Elektra’s state and plan list before looking at anything else. We do not earn a commission from Elektra.

What do Midi Health alternatives cost in a year?

Published first-year care or plan costs range from a $99 one-time Wisp consult to more than $2,400 in one Winona patch-plus-progesterone renewal scenario. Those figures are not interchangeable: some include only a visit, some include medication, and some add optional visits. Insurance costs cannot be responsibly annualized without the reader’s deductible, copay, coinsurance, and formulary.

The assumptions come before the numbers

We do not publish an “average insured Midi year” because it would create false precision. Midi states that insured cost sharing varies. A universal annual insured total cannot be verified from a provider page.

The table below uses only reproducible sticker-price arithmetic. For broader pharmacy, insurance, and provider scenarios, see the 2026 HRT cost guide.

Three clinician visits when showing a per-visit care scenario: one initial and two follow-ups.
Twelve months for ordinary monthly plans.
13.04 renewal cycles only where Winona’s 30-day supply is processed every 28 days: 365 ÷ 28.
Medication, labs, shipping, taxes, insurance cost sharing, and dose differences are excluded unless the row explicitly includes them.
These are price scenarios, not recommended regimens.

Path	Reproducible arithmetic	Published first-year scenario	What is not included
Wisp consult	$99 once	$99	Retail-pharmacy medication, outside evaluation, labs if needed
Evernow membership	$420 for 12 months	$420	Optional video-visit copay or $150 self-pay visit; medication
MyMenopauseRx, three self-pay visits	$150 × 3	$450	Medication and labs
Evernow, three self-pay video visits	$150 × 3	$450	Medication and optional membership
Elektra, three self-pay visits	$249 + $149 + $149	$547	Medication and labs
Midi, three cash visits	$250 + $150 + $150	$550	Medication and labs
Gennev, three self-pay doctor visits	$250 + $199 + $199	$648	Medication and labs
Alloy oral estradiol + progesterone scenario	$49 consult + 12 × ($39.99 + $23)	about $805	Any price change, different product, dose, or add-on
Hers oral plan starting price	$79 × 12	$948	Any plan above the advertised starting price
Winona combined compounded body cream scenario	$89 × 13.04 every-28-day cycles	about $1,161	Different dose/product and any plan change
Alloy patch + progesterone scenario	$49 + 12 × ($100 + $23)	$1,525	Different product, dose, or add-on
Hers patch plan starting price	$134 × 12	$1,608	Any plan above the advertised starting price
Winona patch + progesterone scenario	($149 + $39) × 13.04	about $2,452	Different dose/product and any plan change
Sesame menopause subscription	Confirm during booking	Not annualized	The current public service page does not provide one stable universal checkout total we can reproduce for every reader

The number that changes the decision

A universal insured annual total would create false precision. It can look useful while hiding the deductible, coinsurance, copay, formulary, and number of visits that determine the actual cost.

The real comparison is sharper:

If Midi is in network and you have low specialist cost sharing, it may beat every cash plan.
If your deductible is high, a published cash visit can be more predictable.
If you want medication included, compare the exact product and billing interval, not the monthly headline.
If you need only one consult, multiplying every service by three would punish one-time models unfairly.

Midi is not the enemy here. Midi is the benchmark. Measure the alternative against the problem you are actually paying to solve. For the provider-specific evidence behind that benchmark, read our full Midi Health review.

If a $150 self-pay visit and pharmacy choice solve your problem, check MyMenopauseRx’s current state list and insurance participation. We earn nothing from MyMenopauseRx.

Who can actually treat you in your state?

State availability has at least five layers: clinician licensure, program availability, medication-specific prescribing rules, pharmacy fulfillment, and insurance-network participation. “Available nationwide” does not guarantee that a particular controlled substance, compounded prescription, insurer, or pharmacy route is available where you are physically located during the appointment.

Here is the verified state picture that matters:

Midi: clinical care in all 50 states; testosterone in 24 states plus DC.
Evernow: all 50 states plus DC.
Gennev: all 50 states.
MyMenopauseRx: its live state list contains 39 states plus DC.
Elektra: clinical care in 16 states; coaching can be broader, but coaching is not prescribing.
Winona: 37 states plus Puerto Rico; its published list excludes 13 states and DC.
Alloy, Wisp, Sesame, and Hers: eligibility is checked during intake or booking; do not rely on a generic “ships nationwide” statement as proof that your exact clinical service and prescription are available.

A provider has to clear all of these gates:

A clinician can legally see you where you are sitting during the visit.
The menopause program is open in that jurisdiction.
The specific medication can be prescribed there.
A pharmacy can dispense or ship it there.
Your insurer has a contract for that provider and state, if you are using insurance.

Moving or spending months away from home can change the answer. Telehealth licensure usually follows the patient’s physical location at the time of care, not the address printed on the insurance card.

Do any Midi Health alternatives include labs?

Sesame is the only provider in this comparison that publicly bundles a named five-test panel into its menopause subscription when the clinician orders it: complete blood count, HbA1c, thyroid testing, lipid panel, and comprehensive metabolic panel. The other clinical providers may order labs when appropriate, but costs usually depend on insurance, laboratory network, and the tests selected.

The five Sesame tests are not a hormone panel. They look for broader health issues that can overlap with or affect menopause care.

Provider	Published lab position	Included in advertised price?
Midi	Clinician may order labs; outside lab and insurance rules apply	No universal included panel
Evernow	Provider may request necessary labs or medical information	No universal included panel
Gennev	Clinician may order testing based on care needs	No universal included panel
MyMenopauseRx	Labs can be ordered through its system; insurance or discounted self-pay pricing applies	No fixed universal panel price
Elektra	Orders labs as appropriate; explicitly says it does not use saliva or urine DUTCH testing	Depends on insurance and test
Sesame	CBC, HbA1c, thyroid, lipid panel, CMP when ordered; state exceptions apply	Yes, under the stated subscription rules
Wisp	Menopause page does not advertise an included lab panel	No included panel advertised
Alloy	No routine included laboratory package advertised for the core menopause plan	No
Hers	No routine included lab package advertised in the published starting price	No
Winona	Says hormone testing is not routinely required; no standard included panel published	No standard included panel

Sesame lists exceptions affecting laboratory fulfillment in Arizona, Oklahoma, South Dakota, Wisconsin, Hawaii, New York, New Jersey, Rhode Island, and North Dakota. Check the current service page during booking because laboratory rules can change faster than the subscription copy.

Do you need hormone levels before menopause treatment?

Do not use “no hormone panel” as an automatic quality red flag. An FDA-approved estradiol/norethindrone label states that serum FSH and estradiol levels have not been shown useful in managing moderate-to-severe vasomotor symptoms or moderate-to-severe vulvar and vaginal symptoms. That does not mean no woman ever needs laboratory testing. It means one hormone snapshot should not be treated as the universal gate to care. See the FDA prescribing information.

Labs earn their money when they answer a real clinical question — for example, evaluating thyroid disease, anemia, metabolic risk, medication safety, or another condition that may change the plan.

Which Midi Health alternatives prescribe testosterone?

Midi publishes a testosterone pathway in 24 states plus DC, and Elektra says some of its clinicians can prescribe testosterone to patients in New York. MyMenopauseRx also publishes access, but its pages are not fully aligned: its FAQ says direct prescribing in Illinois and possible PCP coordination elsewhere, while clinician pages list additional prescriber-specific states. Sesame prohibits controlled-substance prescribing online, and Alloy says it does not offer testosterone therapy.

This section needs to be precise because testosterone is not a casual add-on.

Midi’s current testosterone jurisdictions

Midi lists: Arizona, California, Colorado, Delaware, Florida, Iowa, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, New Jersey, New Mexico, Nevada, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia, Washington, and the District of Columbia. Check the live Midi testosterone page before booking because controlled-substance access can change by state.

Midi describes its women’s testosterone offering as compounded testosterone. The finished compounded medication is not FDA-approved and has not been reviewed by FDA for safety, effectiveness, or quality before marketing.

MyMenopauseRx publishes a second pathway — but its state language conflicts

MyMenopauseRx’s FAQ currently says it directly prescribes testosterone for patients located in Illinois and may work with a patient’s local primary-care clinician elsewhere. Its refill guide requires a video appointment and periodic laboratory monitoring, while clinician-specific pages list broader state sets for some prescribers. Do not assume the general state list equals direct testosterone access. Ask who will prescribe, in which state, and whether coordination with a local clinician is required before you pay.

Elektra publishes testosterone access in New York

Elektra’s current FAQ says a number of its clinicians can prescribe testosterone to patients who reside in New York. That statement does not establish access in Elektra’s other clinical states. Confirm that the assigned clinician provides this service and that the required evaluation, follow-up, laboratory monitoring, pharmacy, and out-of-pocket costs are clear before booking.

The federal facts do not bend for telehealth

There is no FDA-approved testosterone formulation specifically indicated for women in the United States.
Testosterone is a Schedule III controlled substance.
A prescription from an appropriately licensed clinician is required.
State rules, federal telemedicine rules, quantity limits, follow-up requirements, laboratory monitoring, and pharmacy availability can all affect access.

Sesame states that its providers cannot prescribe controlled substances online. Alloy states that it does not offer testosterone therapy. A provider article discussing testosterone is not evidence that the provider prescribes it.

If none of the published Midi, Elektra, or MyMenopauseRx pathways applies where you are located, the correct next step is an in-person clinician — not a platform whose website talks about libido without publishing a prescribing program.

If no published pathway applies in your state, the next step is an in-person clinician.

FDA-approved, compounded, or generic — which lane are you in?

An FDA-approved drug has been reviewed for safety, effectiveness, and manufacturing quality for its approved application. An FDA-approved generic meets FDA requirements as a substitute for a reference drug. A compounded drug is prepared for an individual patient and is not FDA-approved. Facility registration, state licensure, or use of USP-grade ingredients does not approve the finished compounded prescription.

Get this wrong and the price comparison stops meaning anything.

Wording	What it means
FDA-approved	FDA reviewed the specific finished drug through an approval process for its labeled use
FDA-approved generic	An FDA-approved product meeting applicable standards for a reference drug
Commercially manufactured	Made by a drug manufacturer; confirm FDA status and exact product rather than assuming
FDA-regulated facility	The facility may be registered, inspected, or subject to federal requirements; that does not approve every drug it makes
Bioidentical	Describes chemical structure, not regulatory status; FDA-approved and compounded products can both be described this way
Compounded	Prepared by a pharmacy for a patient; the finished drug is not FDA-approved and is not reviewed before marketing in the same way as an approved drug

The common mistake is thinking “bioidentical” means “compounded.” It does not. Commercial estradiol patches and micronized progesterone capsules can be both bioidentical and FDA-approved.

Where the providers sit

Gennev: publishes an FDA-approved hormonal and non-hormonal medication model.
MyMenopauseRx: publishes FDA-approved therapeutic options and sends prescriptions to retail pharmacies.
Elektra: explicitly says it prescribes only FDA-approved hormonal and non-hormonal medications, not compounded hormone therapy.
Alloy: its core menopause list publishes FDA-approved estradiol and progesterone options; other Alloy categories include compounded products, so judge the exact item, not the logo.
Midi: core care can include commercially manufactured FDA-approved prescriptions; its testosterone and separately identified Custom Rx products are compounded.
Evernow, Wisp, Sesame, and Hers: status depends on the exact prescription. Ask for the product name, manufacturer, and pharmacy.
Winona: mixed lane. Its product pages present commercially manufactured patch, tablet, and capsule options alongside compounded creams.

Winona’s own FDA wording conflicts

Winona’s help center says broadly that “Winona’s treatments are not FDA approved” because its 503A pharmacies compound personalized prescriptions. Yet its product and FAQ materials also distinguish FDA-approved patch, tablet, and progesterone-capsule products from compounded creams.

The correct conclusion is not “everything is compounded” or “everything is FDA-approved.” It is: Winona offers a mixed catalog, and its umbrella language conflicts. Ask for the exact product, manufacturer, NDC if applicable, and dispensing pharmacy before paying.

That ten-second product check is stronger than any company-level badge.

How do the nine Midi Health alternatives actually compare?

The table below combines the disqualifiers most comparisons separate: insurance, cash-price unit, state breadth, medication destination, included medicine, labs, testosterone, and regulatory lane. Those columns reveal the real trade: insurance models preserve pharmacy choice; medication subscriptions create price predictability but narrow flexibility and can introduce renewal friction.

Provider	Insurance	Published cash unit	State position	Medication destination	Medication included?	Lab position	Testosterone pathway?	Medication lane
Evernow	Major commercial plans for eligible video visits	$150 per self-pay video visit; optional $49/$129/$420 memberships	50 states + DC	Local pharmacy or delivery options	Not in visit price; varies by fulfillment	Ordered if needed	Not publicly established	Product-specific
Gennev	Plan-specific commercial coverage	$250 initial; $199 follow-up doctor visit	All 50 states	Patient pharmacy	No	Ordered as needed	Not publicly established	Publishes FDA-approved options
MyMenopauseRx	Seven named insurance groups	$150 per visit	39 states + DC listed	Patient pharmacy	No	Orderable; insurance/self-pay	FAQ: direct in Illinois; other pages vary	Publishes FDA-approved options
Elektra	Commercial + listed Medicare/Medicaid plans by state	$249 initial; $149 follow-up	16 clinical-care states	Patient pharmacy	No	As appropriate; no DUTCH testing	Yes, New York	FDA-approved core care; testosterone is off-label for women
Wisp	Cash-pay consult	$99 once	Intake determines eligibility	Pharmacy selected by patient	No	No included panel advertised	Not publicly established	Exact retail prescription
Alloy	Cash-pay	$49 consult + product subscription	Intake determines eligibility	Shipped by partner pharmacy	Yes, in product price	No included routine panel advertised	No	Core menopause products FDA-approved; other categories include compounds
Sesame	Cash-pay service	Confirm during booking	Broad access; lab exceptions by state	Patient pharmacy	No	Five tests included when ordered	No controlled substances online	Exact retail prescription
Hers	Cash-pay	From $79 oral / $134 patch monthly with 12-month plan	Intake determines eligibility	Shipped medication	Yes	No routine included panel advertised	Not publicly established	Exact prescribed product; pending FTC/state billing, cancellation, and privacy allegations
Winona	Does not bill insurance directly	Product subscription; examples $89 cream, $149 patch, $39 progesterone	37 states + Puerto Rico	Shipped medication	Yes	No standard included panel	Not publicly established	Mixed: FDA-approved products + compounded creams

The columns that disqualify people before price

Government insurance: Elektra is the only main-table provider publishing Medicare and Medicaid contracts. Midi excludes Medicaid/Medi-Cal treatment entirely.

Testosterone: Midi publishes a 24-state-plus-DC pathway. Elektra publishes access in New York. MyMenopauseRx publishes a pathway too, but its FAQ and clinician-specific state language need to be reconciled during booking.

State: Elektra’s 16-state clinical footprint and Winona’s 37-state footprint can end the decision before pricing starts.

Medication destination: Gennev, MyMenopauseRx, Elektra, Wisp, and often Midi preserve retail-pharmacy choice. Alloy, Hers, and Winona are built around shipped product plans.

Billing unit: every-28-day processing creates roughly 13 cycles per year, not 12. That one line changes Winona annual math materially.

What is the biggest drawback of Midi Health?

Midi’s biggest drawback is cost uncertainty when insurance is involved, followed by a $250 cash entrance price and separate medication and lab costs. Its strength is the same structure viewed from the other side: standard menopause visits are per visit, prescriptions generally go to the patient’s pharmacy, and there is no mandatory care membership attached to ordinary visits.

Here is the damaging admission about the provider at the center of this page.

Midi does not give every patient one predictable all-in number. Its initial self-pay visit costs more than Evernow’s or MyMenopauseRx’s self-pay visit and more than Wisp’s one-time consult. An eligibility check cannot promise what the insurer will assign to your deductible.

If predictability is the priority, a known self-pay visit or medication-included plan is a better fit. We do not earn a Midi commission on this page. Good.

But the model also avoids a different problem: you are not automatically paying a care membership every month merely to keep access to standard menopause visits. The prescription can go through your pharmacy benefit, and you can compare generic, brand, local, and mail-order options instead of being locked into one bundled shipment.

That is the trade:

Midi: less all-in predictability, more pharmacy and insurance flexibility.
Medication subscription: more predictable sticker price, less separation between provider and seller, plus renewal deadlines.
Known cash visit: predictable clinical fee, medication still separate.

The correct alternative is the one that fixes the failure mode you actually experienced.

What do Midi’s reviews and advertising record actually show?

Published patient comments praise access and feeling heard; public complaints commonly raise billing, continuity, and support friction. Those are individual experiences, not outcome evidence. The verified regulatory item is a February 2026 National Advertising Division inquiry in which Midi permanently discontinued a challenged symptom-relief claim; NAD did not decide the claim on its merits.

The advertising record

On February 25, 2026, BBB National Programs’ National Advertising Division reported that it challenged a Midi social-media claim about the percentage of patients finding relief within two months. Midi permanently discontinued the challenged claims during the inquiry. NAD therefore did not review the claims on their merits and treated them, for compliance purposes, as though discontinuance had been recommended. Read the NAD decision summary.

That is not a safety finding. It is not proof that Midi care is ineffective. It is a verified advertising event, and it belongs on a page asking whether the company should be trusted.

Real service quotes, labeled honestly

These quotes are published by the providers themselves. They are not independently authenticated, they do not prove a typical result, and we use them only to illustrate service experience.

“Midi was so easy: I got a same day appointment and they took my insurance.” — Victoria W., published by Midi

“For the first time, someone actually listened to me during my visit.” — Shyla D., published by Midi

“The provider was compassionate and friendly, listened to my concerns and understood all of them.” — Gennev patient, published by Gennev

A positive quote does not erase a complaint. A complaint does not establish a complaint rate. The useful question is whether the recurring theme matches your dealbreaker: billing uncertainty, clinician continuity, response time, or care format.

We deliberately do not use testimonials to support medication efficacy, safety, weight loss, or a guaranteed symptom result.

What do other “Midi Health alternatives” pages get wrong?

The most common errors are stale prices, company-wide FDA labels applied to mixed catalogs, insurance carrier logos treated as proof of exact network status, and annual totals built from 12 months when the provider processes a 30-day supply every 28 days. The correction is simple: compare the exact product, plan, state, and billing interval.

Here is the provider-stated-versus-verified audit that changes a reader’s decision:

Common comparison claim	What current primary pages show	Practical fix
“Gennev starts at $199”	A doctor visit is now $250 initial and $199 follow-up; $199 also appears for an initial dietitian visit	Compare the clinician type, not one orphaned price
“Gennev only names three insurers”	Its live plan lookup includes Aetna, Anthem, Cigna, S&S/Meritain, and some out-of-network arrangements	Search the exact plan
“MyMenopauseRx is $99”	Its current site publishes $150 per self-pay virtual visit	Use the live treatment-cost page, not an older landing page
“Evernow hides the pay-per-visit cash price”	Its current FAQ publishes $150 self-pay per video visit	Remove the old criticism
“Alloy’s estradiol patch is $74.99”	The current solutions page publishes $100 for a one-month supply	Rebuild the annual scenario
“Only Midi has an online testosterone pathway”	Elektra publishes access in New York; MyMenopauseRx publishes access too, but its FAQ and clinician-specific state language conflict	Confirm the exact prescriber, state, product, and follow-up requirements before paying
“Winona is compounded-only”	Its current materials show a mixed catalog: commercially manufactured patch/tablet/capsule options and compounded creams	Ask for the exact product and NDC where applicable
“Winona costs 12 monthly payments a year”	Its help language says a 30-day supply processes every 28 days	Use 13.04 cycles for that scenario

This is why we re-check before publishing. A negative is not a collectible. When a provider fixes a page or changes a price, the article has to change too.

Postmenopausal bleeding is not a provider-shopping question
Bleeding after menopause needs clinical evaluation. Do not let a product page normalize it for you, and do not let a comparison article tell you which subscription to buy first. Contact a clinician who can evaluate the cause and arrange in-person examination, imaging, or tissue assessment when indicated.

The next step is clinical evaluation, not another provider checkout.

How do you switch without losing your prescription?

Do not cancel first. Check the pharmacy record and remaining refills, document your exact product and dose, book the new intake, let the new clinician evaluate you independently, and cancel any recurring plan in writing only after you know your runway. A retail-pharmacy refill may remain valid, but a new provider is never obligated to continue the same regimen.

This is the fear underneath the search. Take it apart in order.

Check the pharmacy account first. Record remaining refills and the prescription expiration date.
Photograph every label. Capture product name, strength, directions, manufacturer, NDC if present, dispensing pharmacy, and prescriber.
Download your records. Save the medication list, relevant visit notes, labs, imaging, and dates of dose changes.
Book the new intake before canceling. New-patient availability is the variable you do not control.
Tell the new clinician about the transition. The new clinician must make an independent prescribing decision.
Wait for the new prescription plan. Do not assume a platform will refill a compounded product, controlled substance, or exact brand.
Cancel recurring billing in writing. Screenshot the confirmation and the next renewal date.
Confirm the pharmacy has the new prescription. A sent prescription is not the same thing as medication in stock.

Current cancellation and renewal rules that matter

Provider	Published rule to act on
Midi	Standard menopause visits are per visit rather than a mandatory care membership. Separately enrolled product subscriptions can have their own renewal terms. Cancel scheduled appointments under the current appointment policy.
Evernow	Pay-per-visit and membership are different products. Cancel the membership through the account before its next renewal; optional video visits may create separate charges.
Elektra	Cancel or reschedule at least 24 hours ahead to avoid the published $50 charge.
Alloy	Its terms require subscription cancellation at least 7 days before the period ends and shipment cancellation or pause at least 5 business days before processing.
Winona	A 30-day supply can process every 28 days; once an order processes, the help center describes a short 24-hour cancellation/refund window. Act before processing, not after shipment.
Wisp	The $99 menopause consult is a one-time clinical fee; medication is filled separately at a pharmacy if prescribed.
Hers	Check the account’s next charge date and current subscription terms before treatment is approved. A pending FTC-and-state lawsuit alleges Hims & Hers used deceptive subscription billing, made cancellation difficult, and shared sensitive health information; the allegations have not been adjudicated.
Sesame	Its service page describes refund and renewal timing around the first visit and billing cycle; confirm the live rule in the account before the next charge.

“Cancel anytime” means you can stop future renewal. It does not automatically promise a refund for a processed order, completed visit, or shipped medication.

Moving care? Use Find My HRT Path to build your switch checklist — state, insurance, medication route, refill runway, and the questions to bring to the new intake.

Is there a cheaper route that is not another telehealth company?

Yes. If an existing primary-care clinician, gynecologist, or menopause specialist will evaluate and prescribe for you, paying the visit cost and filling an FDA-approved generic at your own pharmacy can be cheaper than a bundled platform. The exact total depends on the drug, dose, pharmacy, ZIP code, insurance formulary, and follow-up schedule, so obtain a live quote rather than using a national coupon headline.

This answer earns us nothing. It is still the first route worth checking.

Try these before buying another subscription

Check your employer benefits. Midi, Maven, or another menopause benefit may already be included through work.
Search The Menopause Society’s practitioner directory. It can surface menopause-focused clinicians who see patients in person or by telehealth.
Call the insurer, not only the clinic. Ask for an in-network gynecologist, primary-care clinician, or women’s-health specialist with telehealth availability.
Ask for the exact prescription price. Compare insurance, the pharmacy’s cash price, and a manufacturer program where applicable.
Ask whether your clinician can manage follow-up remotely after an initial in-person visit. A hybrid route can preserve local examination access without requiring every check-in to be in person.

The barrier is often not the retail price of generic estradiol or progesterone. It is finding a clinician who is comfortable evaluating the full situation and following the prescription over time.

What changed in FDA labeling in 2026?

The FDA approved updated labeling in February 2026 for six specific menopausal hormone therapy products: Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva. The change did not automatically rewrite the labeling for every menopausal hormone therapy product. Read the FDA announcement.

A labeling change is not a personalized clearance for treatment. It is one reason to bring current prescribing information into a new conversation rather than assuming a refusal made years ago reflects today’s label.

What about compounded providers like Inner Balance?

Inner Balance’s Oestra is a compounded vaginal estradiol-and-progesterone cream. The finished prescription is not FDA-approved and has not been reviewed by FDA for safety, effectiveness, or quality. It belongs in a separate decision lane from commercially manufactured FDA-approved estradiol and progesterone products, even when a licensed clinician and pharmacy are involved.

The compounded lane exists for legitimate patient-specific reasons: an allergy to an excipient, a dose or dosage form that is not commercially available, or another documented need a clinician determines cannot be met by an approved product.

The boundary is just as real: pharmacy licensure, use of USP-grade ingredients, 503A status, 503B registration, or FDA inspection of a facility does not make the finished compounded drug FDA-approved.

The American College of Obstetricians and Gynecologists states that compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist. See ACOG Clinical Consensus No. 6 and the FDA’s compounding Q&A.

Ask these questions before considering a compounded prescription:

What exact clinical need cannot be met with an FDA-approved product?
Is the prescription prepared by a 503A pharmacy or a 503B outsourcing facility?
What are the exact ingredients, strengths, and dosage form?
What testing and quality documentation are available for the dispensed product?
What is the beyond-use date and storage requirement?
Who handles adverse reactions and dose adjustments?
What will the first 90 days cost, including consults, medication, shipping, and required follow-up?
Is there an FDA-approved alternative, and why is it not being used?

A compounded prescription is a clinician decision, not a reason to accelerate checkout. For the provider-to-provider distinction, see Inner Balance vs Midi Health.

How did The HRT Index verify these Midi Health alternatives?

We compared provider-published prices and policies on the same date, normalized unlike billing units, checked medical and regulatory claims against FDA, ACOG, DEA, and prescribing information, and recorded unresolved conflicts instead of guessing. We did not enroll or test care. The resulting table is an editorial research dataset, not a provider score.

Our review framework is The HRT Index Verification Standard. It uses five pillars, always in this order.

1. Clinical legitimacy

Who evaluates the patient, what credentials are published, whether the visit is live or asynchronous, and whether the provider explains the prescribing relationship.

The strongest public clarity in this group comes from physician-led or named clinical teams such as Gennev, MyMenopauseRx, Elektra, Midi, and Alloy. The weakest category-wide disclosure is assignment before payment: most platforms do not guarantee the exact clinician you will receive.

2. Care quality

Visit length, continuity, access to follow-up, communication method, and whether the model can coordinate with local care.

Gennev publishes 30-minute doctor visits. Elektra publishes 30-minute initials, 15-minute follow-ups, and a clinician-plus-coach model. MyMenopauseRx lets patients select the same specialist. Evernow distinguishes 90-day portal access under pay-per-visit from ongoing access under membership.

No marketing page can prove how listened-to you will feel. That is why testimonials are labeled as individual experiences rather than converted into a score.

3. Medication fit

FDA-approved versus compounded, route, pharmacy choice, controlled-substance access, and whether the provider sells the medication it prescribes.

Elektra and Gennev make the cleanest FDA-approved-only statements. Winona requires the most product-level checking because its catalog is mixed and its umbrella FDA wording conflicts. Midi has both a conventional retail-pharmacy lane and clearly labeled compounded offerings such as testosterone.

4. Price transparency

Whether a reader can reproduce the first-year number from public prices and billing intervals.

Wisp, Midi, Gennev, MyMenopauseRx, Elektra, Evernow, Alloy, Hers, and Winona publish enough to calculate at least one scenario. Sesame’s exact current total must be confirmed during booking, so we refuse to invent an annual figure.

The biggest category-wide trap is not a hidden price. It is a visible price with an unclear unit: per visit, per month, per 28 days, per three-month shipment, or “starting at” under a long commitment.

5. Access

State licensure, insurance, Medicare/Medicaid, age rules, laboratory network, pharmacy fulfillment, and controlled-substance restrictions.

Midi, Evernow, and Gennev lead on geographic breadth. Elektra leads the government-insurance case but only in its current clinical states and plan contracts. Winona is the clearest age disqualifier because it says it does not prescribe HRT for women 60 and older.

Still confirm these during intake or checkout

These are not failures. They are facts a public page cannot settle for every reader.

Your exact insurer network and remaining deductible.
The clinician legally available in your state on the appointment date.
The exact product, manufacturer, pharmacy, and FDA status.
The drug formulary tier and prior-authorization rule.
The real first shipment and renewal date.
Whether a promotion changes only the first order or the ongoing price.
Any laboratory, imaging, or in-person examination required after intake.
Whether the clinician will continue your current regimen or recommend something different.

Found a changed price or policy? Send a correction. We date material updates.

Which Midi Health alternative should you choose?

Choose the provider that removes your actual wall: Evernow or Gennev for broad commercial-insurance alternatives, MyMenopauseRx for a $150 visit and pharmacy choice, Elektra for Medicare or Medicaid where covered, Wisp for a low one-time consult, and Alloy, Hers, or Winona for medication delivery. Stay with Midi when its network and model already fit.

Find yourself here.

You have an in-network PPO and one bad visit

Stay with Midi long enough to request reassignment and verify the next visit cost. Switching can reset records and refill timing without solving the underlying issue.

Your commercial plan does not work with Midi

Start with Evernow or Gennev. Evernow publishes all-state access, four major commercial carrier groups, and a $150 self-pay video fallback. Gennev offers 30-minute physician visits nationwide and a live plan lookup.

Check Evernow’s current insurance and pay-per-visit terms or search Gennev’s plan lookup. We earn nothing from either.

You want a lower cash visit and your prescription at your own pharmacy

Start with MyMenopauseRx. The current self-pay price is $150 per virtual visit, not the old $99 figure. It names seven insurance groups, lets patients select the same specialist, and sends FDA-approved prescriptions to a local pharmacy when appropriate.

Check MyMenopauseRx state eligibility or read our full MyMenopauseRx review. We earn nothing.

You have Medicare or Medicaid

Start with Elektra if its clinical service and your plan are available where you live. If not, use your own plan directory. No other main-table provider publishes the same government-insurance position.

Check Elektra’s state-by-state insurer list. We earn nothing.

You want one low consult and no care subscription

Start with Wisp. The menopause consult is $99 and a prescription, if approved, goes to the pharmacy you choose. Medication is extra, and the public menopause page does not promise an included lab panel or a longitudinal live-video relationship.

See Wisp’s current menopause consult or compare the models in Midi vs Wisp. We earn nothing.

You want basic bloodwork bundled into the service

Start with Sesame. Its listed panel covers CBC, HbA1c, thyroid, lipids, and CMP when ordered, with state exceptions. None of those five is a hormone panel, and the medicine is separate.

→ Check Sesame’s current menopause booking price and lab rules (Affiliate link.) For the direct two-provider decision, see Sesame HRT vs Midi Health.

You want medication shipped and prefer an FDA-approved core menopause catalog

Start with Alloy first; compare Hers only after reading its current subscription terms. Alloy publishes the exact product menu and a one-time consult fee; Hers publishes lower starting rates tied to a 12-month plan. Alloy’s patch is now $100 a month, so old comparisons using $74.99 are stale.

Hers carries a material unresolved issue: a July 29, 2026 FTC-and-state complaint alleges deceptive billing and cancellation practices and sharing of sensitive health information. The case is pending, so these are allegations rather than findings. We earn nothing from Alloy or Hers on this page.

You want a shipped Winona plan

Winona can fit a reader aged 35–59 who lives in a served state and accepts subscription renewal. Go in with the full picture: 37 states plus Puerto Rico, no direct insurance billing, mixed FDA-approved and compounded products, and 30-day supplies that may process every 28 days.

The compounded combined cream starts at $89 per cycle. The published patch and progesterone prices are $149 and $39. Under every-28-day processing, that patch-plus-progesterone scenario reaches about $2,452 in a year.

→ Check Winona’s exact state, age, product, and renewal eligibility (Affiliate link.)

Testosterone is the reason you are leaving

Check Midi’s live state list, Elektra’s New York pathway, and MyMenopauseRx’s prescriber-specific eligibility. For MyMenopauseRx, confirm whether the platform will prescribe directly or coordinate with a local PCP. If none can legally provide the prescription where you are located, go in person. Do not substitute a libido product or DHEA page for a published Schedule III prescribing pathway.

→ Check Midi’s current testosterone-state eligibility (Affiliate link.)

You want the lowest possible total and already have a prescriber

Use your own clinician and pharmacy. Compare the exact prescription at the exact pharmacy. No affiliate plan can honestly beat a route whose only added platform fee is zero.

None of these fits cleanly

That is not indecision. It means the filter is doing its job.

Still not sure which HRT program is right for you? Take our free matching quiz.
→ Find My HRT Path — match your state, insurance, age, medication route, and risk history to the providers that can actually treat you, while flagging when online care is not the right starting point.

Midi Health alternatives: frequently asked questions

Is there a cheaper alternative to Midi Health?

Yes for some cash-paying patients. Wisp publishes a $99 one-time consult, while Evernow and MyMenopauseRx publish $150 self-pay visits. For an insured patient, Midi may still cost less if it is in network and the plan has favorable specialist cost sharing. Medication and labs remain separate in all of those visit-price comparisons.

Which online menopause clinics take insurance?

Midi, Evernow, Gennev, MyMenopauseRx, and Elektra publish commercial-insurance pathways. Elektra also lists Medicare and Medicaid contracts in specific states. Coverage depends on the exact plan, state, medical group, deductible, and service. A carrier logo is not proof that the specific visit is in network.

Does Midi Health take Medicare?

Midi does not bill Medicare or Medicare-related plans. It says Medicare beneficiaries may be seen as self-pay patients but cannot submit claims related to Midi visits, medications, or associated services.

Can I use Midi Health if I have Medicaid?

No under Midi’s current policy. Midi says it cannot treat Medicaid or Medi-Cal patients even as self-pay. Elektra publishes Medicaid contracts in certain states; otherwise use the member directory for an in-network local or telehealth clinician.

Will I lose my prescription if I leave Midi?

Not automatically, but do not assume continuity. Existing retail-pharmacy refills can remain valid until they are used or expire, subject to the prescription and law. A new clinician must evaluate you independently and may not continue the same product or dose. Check the refill count, book the new intake, then cancel recurring services.

Is Gennev cheaper than Midi?

Not at current self-pay sticker prices. Gennev publishes $250 for an initial doctor visit and $199 for follow-ups; Midi publishes $250 and $150. Gennev may still be the better alternative if its physician-led 30-minute model or exact insurance contract fits you better.

Is MyMenopauseRx still $99?

Its current main site publishes $150 per self-pay virtual visit. Older pages or comparisons showing $99 are stale. Insurance cost sharing depends on the exact plan.

What is the difference between Midi and Alloy?

Midi is primarily a visit-based virtual clinic that can bill insurance and usually sends prescriptions to the patient’s pharmacy. Alloy is a cash-pay medication-delivery model with a one-time consult fee, ongoing messaging, and product subscriptions. Midi separates care and medicine; Alloy bundles the prescribed product into the product price.

Does Evernow take insurance?

Evernow says eligible video visits can use major commercial plans including UnitedHealthcare, Aetna, Anthem, and Blue Cross Blue Shield. It does not currently support Medicare or Medicaid. Its optional membership fees are not insurance-covered, and self-pay video visits are $150.

Which alternative includes labs?

Sesame publishes the clearest included panel: CBC, HbA1c, thyroid, lipid panel, and CMP when the provider orders them, with state exceptions. Other providers may order labs, but the charge usually depends on insurance and the laboratory. No provider should order a test merely because it makes a subscription look more complete.

Which Midi alternatives prescribe testosterone?

Midi publishes a pathway in 24 states plus DC. Elektra says some clinicians can prescribe testosterone to patients in New York. MyMenopauseRx’s FAQ says direct prescribing in Illinois and possible PCP coordination elsewhere, while clinician pages list additional prescriber-specific states; confirm the exact pathway before booking. Testosterone is Schedule III, requires a prescription, and has no FDA-approved formulation specifically indicated for women in the US. Sesame prohibits controlled-substance prescribing online, and Alloy says it does not offer testosterone therapy.

Is Winona compounded or FDA-approved?

Both lanes appear in its catalog. Winona publishes compounded creams and also presents commercially manufactured patch, tablet, and capsule options. Its umbrella help-center language conflicts, so ask for the exact product name, manufacturer, NDC if applicable, and dispensing pharmacy. Never infer regulatory status from “bioidentical.”

How do I cancel Midi Health?

Standard Midi menopause visits are charged per visit rather than through a required monthly care membership, so you can stop booking future visits. Cancel any scheduled appointment under the current appointment policy. Separately enrolled product subscriptions, if any, follow their own terms; check the account rather than assuming nothing renews.

Is Midi Health worth it?

Midi can be worth it for a woman whose plan covers the clinic, who wants menopause-focused video care in any state, and who prefers prescriptions sent through her pharmacy benefit. It is a poor fit for Medicaid or Medi-Cal patients, anyone needing Medicare billing, or a reader who values one predictable medication-included price more than pharmacy flexibility.

Editorial research by The HRT Index Editorial Team. Educational only — not medical advice and not a substitute for care from a licensed clinician who can examine you. This page is not medically reviewed by a clinician. FDA-approved and compounded medications are labeled distinctly and are not equivalent. Prices, insurance contracts, state access, formularies, and policies change. Last verified August 14, 2026.

Primary sources checked

Compare the care model before you switch.

Read the full Midi Health review, check Midi Health cost and insurance fit, compare Midi and Evernow or Midi and Winona, or use Find My HRT Path before changing prescription care.

Keep reading: